BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30774019)

  • 1. Incidence of infections after therapy completion in children with acute lymphoblastic leukemia or acute myeloid leukemia: a systematic review of the literature.
    Pelland-Marcotte MC; Hwee J; Pole JD; Nathan PC; Sung L
    Leuk Lymphoma; 2019 Sep; 60(9):2104-2114. PubMed ID: 30774019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Infectious Complications in Children With Acute Lymphoblastic Leukemia Treated With Hematopoietic Stem Cell Transplantation.
    Zaucha-Prażmo A; Kowalczyk JR; Drabko K; Czyżewski K; Goździk J; Zając-Spychała O; Wachowiak J; Frączkiewicz J; Gorczyńska E; Kałwak K; Styczyński J
    Transplant Proc; 2017 Nov; 49(9):2183-2187. PubMed ID: 29149980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
    Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct clinical features of infectious complications in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the Nagasaki transplant group.
    Itonaga H; Taguchi J; Fukushima T; Tsushima H; Sato S; Ando K; Sawayama Y; Matsuo E; Yamasaki R; Onimaru Y; Imanishi D; Imaizumi Y; Yoshida S; Hata T; Moriuchi Y; Honda S; Miyazaki Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):607-15. PubMed ID: 23333533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia-A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWP.
    Pichler H; Lawitschka A; Glogova E; Willasch AM; von Luettichau I; Lehrnbecher T; Matthes-Martin S; Lang P; Bader P; Sykora KW; Schrum J; Kremens B; Ehlert K; Albert MH; Kuhlen M; Meisel R; Guengoer T; Strahm B; Gruhn B; Schulz A; Woessmann W; Poetschger U; Peters C
    Am J Hematol; 2019 Aug; 94(8):880-890. PubMed ID: 31095771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia.
    Perko R; Kang G; Sunkara A; Leung W; Thomas PG; Dallas MH
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):130-6. PubMed ID: 25445640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early infections after autologous hematopoietic stem cell transplantation in children and adolescents: the St. Jude experience.
    Srinivasan A; McLaughlin L; Wang C; Srivastava DK; Shook DR; Leung W; Hayden RT
    Transpl Infect Dis; 2014 Feb; 16(1):90-7. PubMed ID: 24256514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extramedullary relapse of acute leukemia after haploidentical hematopoietic stem cell transplantation: incidence, risk factors, treatment, and clinical outcomes.
    Mo XD; Kong J; Zhao T; Xu LP; Zhang XH; Liu DH; Wang Y; Chen H; Yan CH; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):2023-8. PubMed ID: 25196855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of infections and infection-related mortality in children undergoing haematopoietic stem cell transplantation compared to conventional anticancer therapy: a multicentre nationwide study.
    Styczynski J; Czyzewski K; Wysocki M; Gryniewicz-Kwiatkowska O; Kolodziejczyk-Gietka A; Salamonowicz M; Hutnik L; Zajac-Spychala O; Zaucha-Prazmo A; Chelmecka-Wiktorczyk L; Siewiera K; Fraczkiewicz J; Malas Z; Tomaszewska R; Irga-Jaworska N; Plonowski M; Ociepa T; Pierlejewski F; Gamrot Z; Urbanek-Dadela A; Gozdzik J; Stolpa W; Dembowska-Baginska B; Perek D; Matysiak M; Wachowiak J; Kowalczyk J; Balwierz W; Kalwak K; Chybicka A; Badowska W; Szczepanski T; Drozynska E; Krawczuk-Rybak M; Urasinski T; Mlynarski W; Woszczyk M; Karolczyk G; Sobol-Milejska G; Gil L;
    Clin Microbiol Infect; 2016 Feb; 22(2):179.e1-179.e10. PubMed ID: 26493843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unrelated donor umbilical cord blood transplant versus unrelated hematopoietic stem cell transplant in patients with acute leukemia: A meta-analysis and systematic review.
    Lou X; Zhao C; Chen H
    Blood Rev; 2018 May; 32(3):192-202. PubMed ID: 29174416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia.
    Ge L; Ye F; Mao X; Chen J; Sun A; Zhu X; Qiu H; Jin Z; Miao M; Fu C; Ma X; Chen F; Xue S; Ruan C; Wu D; Tang X
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):1040-7. PubMed ID: 24704575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-occurring infections in a contemporary cohort of hematopoietic cell transplantation survivors.
    Sy A; Chanson D; Berano Teh J; Wong FL; Nakamura R; Dadwal S; Armenian SH
    Cancer Med; 2021 May; 10(9):2956-2966. PubMed ID: 33835722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of neutropenia for development of invasive infections at various phases of treatment for hemato-oncological diseases in children.
    Zwitserloot AM; Mavinkurve-Groothuis AM; Galama JM; Verweij PE; Hoogerbrugge PM; Warris A
    Scand J Infect Dis; 2012 May; 44(5):355-62. PubMed ID: 22216875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious profile in children with ALL during chemotherapy: A report of study group for infections.
    Zawitkowska J; Drabko K; Szmydki-Baran A; Zaucha-Prażmo A; Lejman M; Czyżewski K; Zalas-Więcek P; Gryniewicz-Kwiatkowska O; Czajńska-Deptuła A; Kulicka E; Semczuk K; Hutnik Ł; Chełmecka-Wiktorczyk L; Klepacka J; Frączkiewicz J; Salamonowicz M; Tomaszewska R; Zając-Spychała O; Irga-Jaworska N; Bień E; Płonowski M; Bartnik M; Ociepa T; Pierlejewski F; Woszczyk M; Gamrot-Pyka Z; Małas Z; Urbanek-Dądela A; Stolpa W; Musiał J; Styczyński J
    J Infect Chemother; 2019 Oct; 25(10):774-779. PubMed ID: 31101529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late effects in survivors of infantile acute leukemia: a study of the L.E.A program.
    Gandemer V; Bonneau J; Oudin C; Berbis J; Bertrand Y; Tabone MD; Ducassou S; Chastagner P; Brethon B; Dalle JH; Thouvenin S; Poiree M; Plantaz D; Kanold J; Sirvent N; Lutz P; Hamidou Z; Baruchel A; Leverger G; Auquier P; Michel G
    Blood Cancer J; 2017 Jan; 7(1):e518. PubMed ID: 28106878
    [No Abstract]   [Full Text] [Related]  

  • 17. Personalized Prognostic Risk Score for Long-Term Survival for Children with Acute Leukemia after Allogeneic Transplantation.
    Bitan M; Ahn KW; Millard HR; Pulsipher MA; Abdel-Azim H; Auletta JJ; Brown V; Chan KW; Diaz MA; Dietz A; Vincent MG; Guilcher G; Hale GA; Hayashi RJ; Keating A; Mehta P; Myers K; Page K; Prestidge T; Shah NN; Smith AR; Woolfrey A; Thiel E; Davies SM; Eapen M
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1523-1530. PubMed ID: 28527984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia.
    Ruggeri A; Labopin M; Sanz G; Piemontese S; Arcese W; Bacigalupo A; Blaise D; Bosi A; Huang H; Karakasis D; Koc Y; Michallet M; Picardi A; Sanz J; Santarone S; Sengelov H; Sierra J; Vincent L; Volt F; Nagler A; Gluckman E; Ciceri F; Rocha V; Mohty M; ;
    Leukemia; 2015 Sep; 29(9):1891-900. PubMed ID: 25882700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second Hematopoietic Stem Cell Transplantation for Post-Transplantation Relapsed Acute Leukemia in Children: A Retrospective EBMT-PDWP Study.
    Yaniv I; Krauss AC; Beohou E; Dalissier A; Corbacioglu S; Zecca M; Afanasyev BV; Berger M; Diaz MA; Kalwak K; Sedlacek P; Varotto S; Peters C; Bader P
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1629-1642. PubMed ID: 29548831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Measurable Residual Disease (MRD) in Hematopoietic Stem Cell Transplantation for Hematological Malignancies Focusing on Acute Leukemia.
    Czyz A; Nagler A
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.